Arul M. Chinnaiyan is a Howard Hughes Medical Institute Investigator, American Cancer Society Research Professor, and S.P. Hicks Endowed Professor of Pathology and Urology at the University of Michigan. He also serves as the inaugural Director of the Michigan Center for Translational Pathology which is comprised of a multi-disciplinary team of investigators focused on translating “-Omic” technologies to patient care in terms of biomarkers and novel therapeutics. He has co-authored over 350 manuscripts and has been designated an A. Alfred Taubman Medical Research Institute Scholar, and is an elected member of the American Academy of Arts and Sciences, the Institute of Medicine of the National Academy of Sciences, the Association of American Physicians and the American Society for Clinical Investigation. He serves on the Board of Scientific Advisors for the National Cancer Institute. His landmark study thus far is the discovery of TMPRSS2-ETS gene fusions in prostate cancer. TMPRSS2-ETS gene fusions are specific markers of prostate cancer, and presumably function as rational targets for this disease. This finding potentially redefines the molecular basis of prostate cancer as well as other common epithelial cancers.
October 2024
© 2023 American Academy of Sciences & Letters – Dover, DE
Site Designed by Mason Marketing